Newsroom This is where you can keep up with the latest news and browse featured resources, such as scientific articles relevant to our research and our own publications. News Resources
26 Oct 2021 Safety, pharmacokinetics, and antimalarial activity of the novel plasmodiumeukaryotic translation elongation factor 2 inhibitor M5717 A first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
19 Aug 2021 Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
